Supplementary Information
I.
Materials and enzymes S2
II. Expression and purification of human MGAT5 S2
III.
Isolation of symmetric N-glycans N001 and N301 from bovine fetuin S3
IV.
Label N-glycans with 2-AA and AEAB S4
V. Detailed substrate specificity of MGAT5 S5
VI. Substrate specificity study of -galactosidase from Escherichia coli S7
VII. Generation of asymmetric N-glycan structures using LacZ S8
VIII. Glycosyltransferase catalyzed reactions S9
IX. HPLC, MALDI-MS and NMR analysis of purified N-glycans S11 X.
References S31
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry. This journal is © The Royal Society of Chemistry 2017 
III.
Isolation of symmetric N-glycans N001 and N3001 from bovine fetuin Figure S2 . Scheme for the generation of symmetric N-glycans N001 and N301 in one-pot reaction (PNGaseF and neuraminidase) and HPLC separation. Figure S3 . MALDI-MS analysis of N-glycan containing fractions from G25 gel filtration. N301 with larger molecular weight elute faster than N001.
S4
N001 and N301 were generated from one-pot enzymatic digestion of bovine fetuin with PNGaseF and -neuraminidase ( Figure S2) . Briefly, the 20 mL reaction system contains, 400 mg of bovine fetuin, 20 mM Tris-HCl, pH 8.0, 2 mM DTT, 10 units of PNGaseF and 20 units of neuraminidase from Clostridium perfringens. The reaction was allowed to proceed for 2 days at 37 °C and quenched by the addition of 3 volumes of ice-cold acetone and store at 4 °C for 1 hour. Protein was the removed by brief centrifuge, and the supernatant was concentrated by rotatory evaporation. After HPLC analysis using a Water amide column (130 Å, 5 m, 4.6 mm × 250 mm) (Solvent A: Water, Solvent B: Acetonitrile, gradient elution with B% from 65% to 50% in 25 min, flow rate 1 mL/mL), the sample was loaded on a G25 gel filtration column (2.5 cm × 100 cm) for purification. One L from each fraction tube (5 mL each) was spotted on a TLC plate, after dry, visualized by anisaldehyde sugar stain. Tubes with sugars were then analyzed by MALDI-MS and fractions contain N-glycans N001 and/or N301 ( Figure S3) were further separated by HPLC using a Waters amide column (130 Å, 5 m, 10 mm × 250 mm) with similar separation method as described above (flow rate is 4 mL/min). N001 was characterized as did previously, 6 and N301 was characterized by HPLC-ELSD, MALDI-MS, and NMR (see IX). Calculation of yields: Each fetuin protein contains 3 N-glycans, and around 80% is tri-antennary, 16% is bi-antennary as described. 7 Calculation of yields are illustrated as below. The relatively low overall yield maybe caused by 1) fetuin purities and/or 2) incomplete digestion and product loss in purification steps.
IV.
Label N-glycans with 2-AA and AEAB 2-AA (2-Aminobenzoic acid) was used to label N001, N000, N111 and N211 via reductive animation for LacZ specificity studies. AEAB (N-(aminoethyl)-2-amino benzamide) was used to label N301, N300, N391 and N382 as well as previously synthesized N-glycans 6 (label data not shown) for MGAT5 specificity studies. 2-AA or AEAB reactions were performed 8 using the following conditions: Dissolve 5 mg of 2-AA or AEAB in 100 L solution of DMSO/AcOH (7:3 v/v), and add 6 mg of NaCNBH 3 in the previous solution to make final label solution. To every 100 g glycan sample 5 L of labelling solution was added, and incubated in a water bath for 2 h at 65 °C. Labeled glycans were precipitated with acetonitrile (10 volumes) and incubated at -20 °C for 1 h. After centrifugation (13,000 g for 10 min), the supernatant was removed. The pellet was dried in a vacufuge for 15 min. Labeled glycan was diluted in 100 L of water and purified using a Hypercarb Porous Graphitic Carbon LC Column as described. 8 Sample concentration was determined using the peak area and comparing to 10 nmol of known standard (AEAB labelled LNnT tetrasaccharide).
S5

V. Detailed substrate specificity of MGAT5
A detailed substrate specificity study of MGAT5 was performed using 71 chemically or chemoenzymatically synthesized N-glycans and 4 tri-antennary N-glycans obtained in the study as acceptors ( Figure S4 ). Reactions were performed in a 96 well PCR plate, each well (10 L total volume) contains one AEAB 8 labelled N-glycan substrate (50 ), UDP-GlcNAc (10 mM), MES buffer (100 mM, pH 7.0), MgCl 2 (15 mM), 0.2% Triton X-100, BSA (1 mg/ml), and MGAT5 (0.5 mg/mL). Reactions were incubated at 37 °C for 1 h in an Eppendorf thermocycler (Mastercycler Pro), followed by enzyme inactivation at 95 °C for 5 min. A negative control was also set up using N000 as substrate without enzyme. After centrifugation (13,000 g for 10 min), the supernatant was analyzed by HPLC using an analytical Waters XBridge BEH amide column (130 Å, 5 m, 4.6 × 250 mm), detected by UV detector SPD-20A (330 nm) and a fluorescence detector RF-10Axl (330 nm excitation and 420 nm emission). Gradient elution (%B: 65-50% within 30 min) was performed with Solvent A (100 mM ammonium formate, pH 3.2) and Solvent B (Acetonitrile). The conversion rates (average of three replicated reactions, see Table S1 ) were calculated as % = Product peak area/ (Product peak area + Substrate peak area) × 100. The results showed that MGAT5 recognizes N-glycans with an agalactosylated and unprotected GlcNAc residue on the 1,6-mannose branch (N000, N040, N050, and N6000), but not those either without a GlcNAc residue (N020), galactosylated (N211) or with protected GlcNAc residue (N110) on the branch. Among these N-glycans, MGAT5 showed the highest activity towards bi-antennary complex N-glycan structures terminated with GlcNAc at the non-reducing end of both 1,3-and 1,6-mannose branches N000 (72.3% conversion) and slightly decreased activities towards N6000 (61.2% conversion), N210 (45.5% conversion), and N050 (45.6% conversion) indicated that 1,6-fucosylation, protection or removal of GlcNAc residue at the 1,3-mannose branch can be well tolerated. Removal of 1,3-mannose branch N040 (24.0% conversion), galactosylation N111 (26.4% conversion), 1,6 sialyation N113 (37.5% conversion) and 1,3-fucosylation N114 (29.7% conversion) will further decrease the efficiency of MGAT5. The presence of 2,3 sialic acid N112 (10.6% conversion) and N115 (ND), respectively is not preferred by MGAT5. MGAT5 product from Sialyl Lewis x structure N115 was only detected after overnight reaction. MGAT5 also recognized tri-antennary N-glycans (N300, N391, and N382). The enzyme did not recognize N301. Overall, the substrate specificity study using a library of structurally defined N-glycans confirmed that MGAT5 has a strict requirement towards the 1,6-mannose branch, and a fairly relaxed preference towards the 1,3-mannose branch.
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VI.
Substrate specificity studies of -galactosidase from E. coli (LacZ)
Substrate specificity assay of LacZ was performed against chemo-enzymatically synthesized Nglycans isomers N111 and N211 (with 2-AA label at reducing end) as acceptors. Reactions were performed in 10 L total volume, containing N-glycan substrate (50 ), Tris-HCl buffer (100 mM, pH 7.5), and LacZ (1 mg/mL). Reactions were incubated at 37 °C overnight in a water bath. Samples were collected at 0, 5, 10, 15, 20, 30, 45 min, every hour for 8 h, and at 20 h. Reaction was quenched by freezing at -80 °C for 30 min. After centrifugation (13,000 g for 10 min), the supernatant was analyzed by HPLC as above described (fluorescence at 360 nm excitation and 420 nm emission). The conversion rates (average of three replicated reactions, see Table S2 and Figure S5 ) were calculated as % = Product peak area/ (Product peak area + Substrate peak area) × 100. 
VII. Generation of asymmetric N-glycan structures using LacZ
The generation of asymmetric N-glycan core structures was accomplished by selective digestion of N001 ( Figure S6 ) and N301 ( Figure S7 ) by LacZ. Digestion reactions by LacZ were performed in 100 mM Tris-HCl buffer (pH 7.5), containing 2 mM glycan acceptor and 1 mg/mL LacZ. A reaction time course was performed for N001 to determine the best time to collect the intermediate with 1 galactose (Figure S6) . The percent conversion for the time course was monitor by HPLC-ELSD as previously described.
1
Larger scale reaction reactions were allowed to proceed for 3 h for N001 (4 mg, total reaction volume of 1.2 mL) and 3 days for N301 (20 mg, total reaction volume of 5 mL). The reactions were then quenched by freezing in -80 °C for 30 min, followed with concentration by lyophilization. HPLC was then used to purify target glycans using a semi-preparative amide column (130 Å, 5 m, 10 mm × 250 mm). The running conditions are solvent A: 100 mM ammonium formate, pH 3.2; solvent B: acetonitrile; flow rate: 4 mL/min; B%: 60-45% within 25 min. Product containing fraction were then concentrated and lyophilized for characterization. The purity of each glycan was confirmed by HPLC-ELSD using an analytical Waters amide column (130 Å, 5 m, 4.6 mm × 250 mm). 6 The running conditions are solvent A: 100 mM ammonium formate, pH 3.2, solvent B: acetonitrile; flow rate: 1 mL/min; B%: 65-50% within 25 min or 60-45 within 25 min. 
VIII. Glycosyltransferase catalyzed reactions and synthesis of N-glycans
The purified N-glycan core structures were used as substrates in glycosyltransferase catalyzed reactions ( Figure S8 and Figure 5 ). Figure S8 . Generation of more N-glycan cores using MGAT5 and FUT8 catalyzed reactions. S10 FUT8 catalyzed reaction: N-glycan substrate (5 m), GDP-fucose (10 mM), MES buffer (100 mM, pH 7.0), 2 U FastAP, and excess FUT8 (0.5 mg/mL). Reactions were incubated at 37 °C overnight or until substrates were totally converted to product. The reactions were then quenched by boiling for 5 min, and subject to HPLC analysis and purification. MGAT5 catalyzed reaction: N-glycan substrate (5 m), UDP-GlcNAc (10 mM), MES buffer (100 mM, pH 7.0), MgCl 2 (15 mM), 0.2% Triton X-100, BSA (1 mg/ml), and excess MGAT5 (0.5 mg/mL). Reactions were incubated at 37 °C overnight or until substrates were totally converted to product. The reactions were then quenched by boiling for 5 min, and subject to HPLC analysis and purification.
Synthesis of N396: 4 mg of N391 was added to a 0.5 mL reaction system, containing 50 mM Tris-HCl (pH 8.0), 12 mM of GDP-Fuc, 5 mM of MnCl 2 , and excess 1,3-fucosyltransferase from Helicobacter pylori Hp3FT (0.2 mg/mL). FastAP (5 U/1 mL) was also added to digest the reaction byproduct GDP to drive reaction forward. Reactions incubated at 37 °C for 4-24 h, and monitored by HILIC-ELSD (amide column, 4.6 mm × 250 mm under a gradient running condition (solvent A: water, pH 3.4; solvent B: acetonitrile; flow rate: 1 mL/min; B%: 65-50% within 25 min). After over 90% acceptor converted, the reaction was quenched and N394 was purified fir next step. Next step reaction contains 50 mM Tris-HCl (pH 8.0), 4 mM of acceptor glycans (3 mg, total reaction volume of 350 L), 8 mM of UDP-Gal, 5 mM of MnCl 2 , and 20 U of bovine 1,4-galactosyltransferase (bGalT). The reaction was allowed to proceed overnight and subject to HPLC purification to afford N-glycan N395 (3 mg, 93% yield). Finally, N395 was used as a substrate for the synthesis of N396, catalyzed by an 2,6-sialyltransferase from Photobacterium damselae (Pd26ST). Reactions contain 100 mM Tris-HCl (pH 8.0), 4 mM of acceptor glycans (2.6 mg, total reaction volume of 280 L), 8 mM of CMP-Neu5Ac, and 0.05 mg of Pd26ST. Reactions incubated at 37 °C for overnight and subject to HPLC purification (similar as above with the use of 100 mM Ammonium formate as Solvent A instead of water).
The molecular weight of each N-glycans was confirmed by MALDI-MS performed on UltrafleXtreme MALDI TOF/TOF Mass Spectrometer (Bruker). Scan range of MS 1 was according to the molecular weight of N-glycans, and reflector mode was used for N-glycan analysis. Mass spectra were obtained in positive mode with the following voltage settings: ion source 1 (19.0 kV), ion source 2 (15.9 kV), and lens (9.3 kV). The reflector voltage was set to 20 kV. The laser was pulsed at 7 Hz and the pulsed ion extraction time was set to 400 ns. The laser power was kept in the 25-40% range. Structures of key intermediates and asymmetric triantennary N-glycans were confirmed by NMR.
IX. HPLC, MALDI-MS and NMR analysis of N-glycans
All HPLC analyses were performed using the following condition with different gradient elution conditions: Waters amide column: 130 Å, 5 m, 4.6 mm × 250 mm; Solvent A : 100 mM Ammonium formate pH 3.2; Solvent B: Acetonitrile; Flow rate: 1 mL/min). Please note that, due to existence of interconverting -and -anomers of glycans with free reducing end in solution, 9 two adjacent bumps or a large shoulder can usually be observed on the glycan peak in HPLC analysis using a HPLIC column. Such a phenomenon was found and reported repeatedly in HPLC analysis of N-glycans.
1, 6, 10, 11 NMR analysis was only performed for major compounds. The structures of other N-glycans were determined by the activity of FUT8 and MGAT5 towards them.
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